Comment on Tencent Injects US$70M in Health Service Community DXY to Tap China’s Red-hot Healthcare Industry by Review-based Medical Platform The CareVoice Helps Patients to Make Better Healthcare Decisions - TechNode

['Emma Lee', 'More Emma Lee', '.Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow', 'Class', 'Wp-Block-Co-Authors-Plus', 'Display Inline', '.Wp-Block-Co-Authors-Plus-Avatar', 'Where Img', 'Height Auto Max-Width', 'Vertical-Align Bottom .Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow .Wp-Block-Co-Authors-Plus-Avatar'] Comments for TechNode 2014-09-02 00:00:00

DXY plans to invest the capital received from this investment and other resources into developing healthcare products for doctors, pharmaceutical companies, and consumers. Looking ahead, DXY will launch products in three categories — WeChat-based products, mobile apps, and Web-based products. David Feng, Vice President of DXY and Richard Peng, Vice President of Tencent, will become DXY’s board members. With the fast approaching of aging society and government supports, Chinese healthcare industry receiving more attentions from the public. Other startups engaged in this industry are mobile pharmaceutical platform Zhaoniya,and healthcare social platform The CareVoice.